Filing Details

Accession Number:
0001140361-14-005083
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-06 16:54:59
Reporting Period:
2014-02-05
Filing Date:
2014-02-06
Accepted Time:
2014-02-06 16:54:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1176309 Oramed Pharmaceuticals Inc. ORMP Pharmaceutical Preparations (2834) 980376008
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1477733 Mark David Slager 152 West 57Th Street, 9Th Floor
New York NY 10019
No No Yes No
1542836 Regals Fund Lp 152 West 57Th Street, 9Th Floor
New York NY 10019
No No Yes No
1542838 Regals Capital Management Lp 152 West 57Th Street
9Th Floor
New York NY 10019
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-02-05 24,492 $16.32 1,349,585 No 4 P Indirect See
Common Stock Acquisiton 2014-02-06 26,800 $14.96 1,376,385 No 4 P Indirect See
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See
No 4 P Indirect See
Footnotes
  1. Regals Capital Management LP, a Delaware limited partnership ("Regals Management"), the Fund, and David M. Slager ("Mr. Slager"), are the reporting persons (the "Reporting Persons") for the referenced securities. Mr. Slager is Managing Member of the general partner of Regals Management. Regals Management is the investment manager of the Fund. The shares of the issuer's common stock reported herein are held for the account of the Fund.
  2. As a result, each of the Reporting Persons may be deemed to be a beneficial owner of the securities owned by the Fund for purposes of Rule 16a-1(a)(1) under the Securities Exchange Act of 1934, as amended (the "Act"). Pursuant to Rule 16a-1(a)(4) under the Act, Regals Management and Mr. Slager disclaim beneficial ownership in the securities owned by the Fund except to the extent, if any, of their pecuniary interest therein.